Inventor · Munich, DE

Peter Sennhenn

12Patents
2h-index
31Co-inventors
50Inventor score

Filing activity: Jun 13, 2007 → Jan 10, 2025

Most-cited inventions

PatentTitleAreaCited byStatus
US9802956B2 Spiroquinoxaline derivatives as inhibitors of non-apoptotic regulated cell-death Chemistry; Metallurgy 3 Active
US11820751B2 Urolithin derivatives and methods of use thereof Chemistry; Metallurgy 2 Active
US10647687B2 Spiropyrazine derivatives as inhibitors of non-apoptotic regulated cell-death Chemistry; Metallurgy 2 Active
US10280179B2 Spiroquinoxaline derivatives as inhibitors of non-apoptotic regulated cell-death Chemistry; Metallurgy 1 Active
US12351567B2 Urolithin derivatives and methods of use thereof Chemistry; Metallurgy 0 Active
US12421222B2 Substituted quinazolines as HDAC6 inhibitors Chemistry; Metallurgy 0 Active
US12358884B2 Urolithin derivatives and methods of use thereof Chemistry; Metallurgy 0 Active
US12172993B2 Heterocyclic kinase inhibitors and uses thereof Human Necessities 0 Active
US12338440B2 Intracellular kinase associated with resistance against anti-tumour immune responses, and uses thereof Chemistry; Metallurgy 0 Active
US12139480B2 5-thiazolecarboxamide kinase inhibitor and uses thereof Physics 0 Active
US8203001B2 Chemical compounds Human Necessities 0 Active
USRE48992E1 Spiroquinoxaline derivatives as inhibitors of non-apoptotic regulated cell-death General 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.